Bronchial asthma is a chronic disease characterized by an inflammation of the respiratory tract, which causes recurring symptoms: shortness of breath, coughing and mucus formation. Only suitable treatment will help to avoid attacks of suffocation and lead an active lifestyle. People who have been diagnosed with this ailment must undergo a comprehensive course of drug therapy that will eliminate the accompanying symptoms. Any medicine for bronchial asthma should be prescribed only by a narrowly specialized specialist who underwent complex diagnostics and the cause of this pathology development.
Doctors and specialists in the field of asthma distinguish two main elements of the disease: inflammation of the respiratory tract and acute bronchoconstriction (narrowing of the lumen of the bronchi). As studies have shown, reducing and preventing further inflammatory processes is a necessary condition for preventing asthma attacks, hospitalization and death.
Drugs for long-term disease control are taken daily for a long time to achieve and maintain control over persistent asthma (symptoms of the disease that occur more than twice a week, and frequent attacks of suffocation affect activity).
The most effective drugs for long-term control are drugs that stop the inflammation of the respiratory tract (anti-inflammatory drugs), but there are other medications often used together with anti-inflammatory drugs to enhance the effects of the latter.